{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:55:52Z","timestamp":1767984952067,"version":"3.49.0"},"reference-count":56,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.2217\/imt.15.104","type":"journal-article","created":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T18:51:28Z","timestamp":1449600688000},"page":"79-87","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["IL-6 Blockers in Systemic Onset Juvenile Idiopathic Arthritis"],"prefix":"10.1080","volume":"8","author":[{"given":"Patrizia","family":"Barone","sequence":"first","affiliation":[{"name":"Department of Clinical &amp; Experimental Medicine,University of Catania,\rItaly"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossana","family":"Pignataro","sequence":"additional","affiliation":[{"name":"Department of Clinical &amp; Experimental Medicine,University of Catania,\rItaly"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Garozzo","sequence":"additional","affiliation":[{"name":"Department of Clinical &amp; Experimental Medicine,University of Catania,\rItaly"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Leonardi","sequence":"additional","affiliation":[{"name":"Department of Clinical &amp; Experimental Medicine,University of Catania,\rItaly"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,12,7]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V74.1.1.1"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/324073a0"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1987.tb13452.x"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.4.1243.bloodjournal8641243"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3136546"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90411-7"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8511589"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1083901"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8272872"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8272873"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1994.1525"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7701321"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar400"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.23.021704.115806"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.021908.132710"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780340912"},{"issue":"7","key":"e_1_3_2_19_1","first-page":"1403","article-title":"Differences in synovial fluid cytokine levels between juvenile and adult rheumatoid arthritis","volume":"24","author":"De Benedetti F","year":"1997","unstructured":"De Benedetti F, Pignatti P, Gerloni V et al. Differences in synovial fluid cytokine levels between juvenile and adult rheumatoid arthritis. J. Rheumatol. 24(7), 1403\u20131409 (1997).","journal-title":"J. Rheumatol."},{"issue":"7","key":"e_1_3_2_20_1","first-page":"1670","article-title":"Abnormal regulation of interleukin-6 in systemic juvenile idiopathic arthritis","volume":"28","author":"Pignatti P","year":"2001","unstructured":"Pignatti P, Vivarelli M, Meazza C, Rizzolo MG, Martini A, De Benedetti F. Abnormal regulation of interleukin-6 in systemic juvenile idiopathic arthritis. J. Rheumatol. 28(7), 1670\u20131676 (2001).","journal-title":"J. Rheumatol."},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.1.311"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.9.2347.bloodjournal8592347"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2007.12.006"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2443.2005.00900.x"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.5.3492"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3235"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200420945"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2650621"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.24.11924"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo.142.11.8511"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI2629"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11300"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh710"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2009.08.003"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050640"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.061853"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200103)44:3<550::AID-ANR103>3.0.CO;2-5"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0602313"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02475.x"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23437"},{"issue":"4","key":"e_1_3_2_41_1","first-page":"851","article-title":"Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth","volume":"53","author":"Sato K","year":"1993","unstructured":"Sato K, Tsuchiya M, Saldanha J et al. Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth. Cancer Res. 53(4), 851\u2013856 (1993).","journal-title":"Cancer Res."},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2004.03.005"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20944"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar1826"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60454-7"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112802"},{"issue":"10","key":"e_1_3_2_48_1","first-page":"1434","article-title":"Tocilizumab in patients with systemic juvenile idiopathic arthritis: efficacy data from the placebocontrolled 12-week part of the Phase 3 TENDER trial","volume":"62","author":"De Benedetti F","year":"2010","unstructured":"De Benedetti F, Brunner H, Ruperto N et al. Tocilizumab in patients with systemic juvenile idiopathic arthritis: efficacy data from the placebocontrolled 12-week part of the Phase 3 TENDER trial. Arthritis Rheum. 62(Suppl. 10), 1434 (2010).","journal-title":"Arthritis Rheum."},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-9-S1-P164"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20460"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21625"},{"key":"e_1_3_2_52_1","unstructured":"NCT01455701.A phase 1 pharmacokinetic and safety study of Tocilizumab (TCZ) in patients less than 2 years old with active systemic juvenile idiopathic arthritis (sJIA). www.clinicaltrials.gov\/ct2\/show\/NCT01455701?term=NCT01455701&rank=1."},{"key":"e_1_3_2_53_1","unstructured":"NCT00988221. A 24 week randomized double-blind placebo controlled withdrawal trial with a 16 week open-label lead-in phase and 64 week open-label follow-up to evaluate the effect on clinical response and the safety of tocilizumab in patients with active polyarticular-course juvenile idiopathic arthritis. www.clinicaltrials.gov."},{"key":"e_1_3_2_54_1","unstructured":"NCT01603355. An open-label trial to assess the efficacy and safety of tocilizumab in the management of juvenile idiopathic arthritis associated vision-threatening uveitis that is refractory to other modes of systemic immunosuppression. www.clinicaltrials.gov."},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27221"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.03964.x"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00835.x"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200704"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt.15.104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T02:39:53Z","timestamp":1715999993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt.15.104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,7]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.2217\/imt.15.104"],"URL":"https:\/\/doi.org\/10.2217\/imt.15.104","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-06-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-10-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-12-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}